Subtraction Maps Derived from Longitudinal Magnetic Resonance Imaging in Patients with Glioma Facilitate Early Detection of Tumor Progression.
brain neoplasms
disease progression
glioma
magnetic resonance imaging
subtraction technique
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
24 Oct 2020
24 Oct 2020
Historique:
received:
24
08
2020
revised:
07
10
2020
accepted:
20
10
2020
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
30
10
2020
Statut:
epublish
Résumé
Progression of glioma is frequently characterized by increases or enhanced spread of a hyperintensity in fluid attenuated inversion recovery (FLAIR) sequences. However, changes in FLAIR signal over time can be subtle, and conventional (CONV) visual reading is time-consuming. The purpose of this monocentric, retrospective study was to compare CONV reading to reading of subtraction maps (SMs) for serial FLAIR imaging. FLAIR datasets of cranial 3-Tesla magnetic resonance imaging (MRI), acquired at two different time points (mean inter-scan interval: 5.4 ± 1.9 months), were considered per patient in a consecutive series of 100 patients (mean age: 49.0 ± 13.7 years) diagnosed with glioma (19 glioma World Health Organization [WHO] grade I and II, 81 glioma WHO grade III and IV). Two readers (R1 and R2) performed CONV and SM reading by assessing overall image quality and artifacts, alterations in tumor-associated FLAIR signal over time (stable/unchanged or progressive) including diagnostic confidence (1-very high to 5-very low diagnostic confidence), and time needed for reading. Gold-standard (GS) reading, including all available clinical and imaging information, was performed by a senior reader, revealing progressive FLAIR signal in 61 patients (tumor progression or recurrence in 38 patients, pseudoprogression in 10 patients, and unclear in the remaining 13 patients). SM reading used an officially certified and commercially available algorithm performing semi-automatic coregistration, intensity normalization, and color-coding to generate individual SMs. The approach of SM reading revealed FLAIR signal increases in a larger proportion of patients according to evaluations of both readers (R1: 61 patients/R2: 60 patients identified with FLAIR signal increase vs. R1: 45 patients/R2: 44 patients for CONV reading) with significantly higher diagnostic confidence (R1: 1.29 ± 0.48, R2: 1.26 ± 0.44 vs. R1: 1.73 ± 0.80, R2: 1.82 ± 0.85;
Identifiants
pubmed: 33114383
pii: cancers12113111
doi: 10.3390/cancers12113111
pmc: PMC7692500
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Rev Clin Oncol. 2017 Jul;14(7):434-452
pubmed: 28031556
J Clin Oncol. 2011 Jan 10;29(2):124-6
pubmed: 21135277
Cancer. 2008 Jul 15;113(2):405-10
pubmed: 18484594
J Neurosurg. 2003 Jun;98(6):1165-9
pubmed: 12816258
Nat Commun. 2019 Jul 18;10(1):3170
pubmed: 31320621
Neuroimage. 2018 Mar;168:101-118
pubmed: 28392492
Neuro Oncol. 2016 Jan;18(1):96-104
pubmed: 26243790
AJNR Am J Neuroradiol. 2017 May;38(5):923-927
pubmed: 28364006
AJNR Am J Neuroradiol. 2018 Dec;39(12):2187-2193
pubmed: 30385468
Neuro Oncol. 2015 Mar;17(3):332-42
pubmed: 25087230
Radiother Oncol. 2019 Jan;130:180-184
pubmed: 30177373
Clin Neurol Neurosurg. 2013 Jan;115(1):37-43
pubmed: 22537870
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD007415
pubmed: 23633341
Clin Neuroradiol. 2018 Sep;28(3):367-376
pubmed: 28265679
Eur Radiol. 2019 Dec;29(12):7047-7054
pubmed: 31201526
Lancet Oncol. 2015 Nov;16(15):e534-e542
pubmed: 26545842
PLoS One. 2017 Feb 28;12(2):e0173112
pubmed: 28245291
Neurosurg Focus. 2015 Mar;38(3):E11
pubmed: 25727220
J Clin Oncol. 2017 Jul 20;35(21):2439-2449
pubmed: 28640707
J Neurosurg. 2008 Nov;109(5):835-41
pubmed: 18976072
AJNR Am J Neuroradiol. 2015 Aug;36(8):1465-71
pubmed: 26089318
J Neurol. 2017 Sep;264(9):1909-1918
pubmed: 28756606
Lancet Oncol. 2011 Jun;12(6):583-93
pubmed: 21474379
J Neurosurg. 2013 Jun;118(6):1157-68
pubmed: 23495881
JAMA Oncol. 2018 Sep 1;4(9):1254-1262
pubmed: 29931168
Clin Neuroradiol. 2020 Jun;30(2):279-286
pubmed: 31098666
J Magn Reson Imaging. 2020 Oct;52(4):1197-1206
pubmed: 32246803
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
Curr Opin Neurol. 2003 Dec;16(6):643-50
pubmed: 14624071
Cancer Manag Res. 2020 May 07;12:3191-3201
pubmed: 32440216
N Engl J Med. 2008 Jul 31;359(5):492-507
pubmed: 18669428
Radiology. 2000 Nov;217(2):377-84
pubmed: 11058631
Acta Neurochir (Wien). 2009 Nov;151(11):1359-65
pubmed: 19575144
J Neurosurg. 2010 Jan;112(1):10-7
pubmed: 19361270
Acta Neuropathol. 2007 Nov;114(5):443-58
pubmed: 17805551
J Neurooncol. 2015 Mar;122(1):197-203
pubmed: 25577400
Neurosurgery. 2017 Sep 1;81(3):397-415
pubmed: 28486641
J Clin Oncol. 2010 Apr 10;28(11):1963-72
pubmed: 20231676
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
AJNR Am J Neuroradiol. 2018 Jul;39(7):1226-1232
pubmed: 29880479